Preclinical evaluation and first-in-human study of 68Ga- and Al18F-Labeled PSMA/FAP bispecific tracers for prostate cancer imaging
European Journal of Nuclear Medicine and Molecular Imaging · 2026
DOI: 10.1007/s00259-025-07591-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Xinlin Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, 100875, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Glutamate Carboxypeptidase II, Positron Emission Tomography Computed Tomography, Antigens, Surface. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, Joint Funds for the Innovation of Science and Technology, Fujian Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, 100875, China.
- Department of Nuclear Technology and Application, China Institute of Atomic Energy, Beijing, 102413, China.
- Department of PET/CT Diagnostic, Tianjin Medical University General Hospital, Tianjin, 300052, China.
- Department of Nuclear Medicine, Chinese PLA General Hospital, Beijing, 100853, China.
- Department of PET/CT Diagnostic, Tianjin Medical University General Hospital, Tianjin, 300052, China. yaoshaobo008@163.com.
- Key Laboratory of Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, 100875, China. cmc@bnu.edu.cn.
ORCID-Profile: Mengchao Cui
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- Joint Funds for the Innovation of Science and Technology, Fujian Province
Zitieren
APA
Wang, X., Wang, M., Chen, Y., Jian, R., Yu, H., Zhang, X., Zhang, J., Yao, S., Du, J., & Cui, M. (2026). Preclinical evaluation and first-in-human study of 68Ga- and Al18F-Labeled PSMA/FAP bispecific tracers for prostate cancer imaging. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07591-7
Vancouver
Wang X, Wang M, Chen Y, Jian R, Yu H, Zhang X, et al. Preclinical evaluation and first-in-human study of 68Ga- and Al18F-Labeled PSMA/FAP bispecific tracers for prostate cancer imaging. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-025-07591-7
BibTeX
@article{Wang2026,
author = {Wang, Xinlin and Wang, Ming and Chen, Yimin and Jian, Ruotong and Yu, Haonan and Zhang, Xiaojun and Zhang, Jinming and Yao, Shaobo and Du, Jin and Cui, Mengchao},
title = {Preclinical evaluation and first-in-human study of 68Ga- and Al18F-Labeled PSMA/FAP bispecific tracers for prostate cancer imaging},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
doi = {10.1007/s00259-025-07591-7}
}
EUVIMED